TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Neuronetics, Inc. (NASDAQ: STIM) Investor Investigation Over Possible Violations of Securities Laws Announced

  • Investors who purchased shares of Neuronetics, Inc. (NASDAQ: STIM), have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Neuronetics, Inc.
Security
NASDAQ: STIM

Summary

An investigation on behalf of investors of Neuronetics, Inc. (NASDAQ: STIM) shares over potential securities laws violations by Neuronetics, Inc. and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Neuronetics, Inc. (NASDAQ: STIM) concerning whether a series of statements by Neuronetics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Malvern, PA based Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States, Japan, and internationally. Neuronetics, Inc went public in June 2018 and sold 5.5 million shares at $17.00 per share in its initial public offering (IPO).

Since then, shares of Neuronetics, Inc. (NASDAQ: STIM) declined to as low as $10.91 per share on July 23, 2019.

Start Monitoring Your Investments